ACTOBIO THERAPEUTICS

actobio-therapeutics-logo

ActoBio Therapeutics develops therapeutic agents that treat a number of diseases, primarily on disease areas with high unmet needs. It develops a new class of therapeutic agents called ActoBiotics, a targeted, microbe-based, specifically designed agents that locally provide potential disease-modifying therapeutics to treat a range of disorders, such as immune-related diseases. ActoBiotics is based on the safe food-grade bacterium, Lactococcus lactis, which is used in the making of cheeses and ot... her foods. Lactococcus lactis is engineered to develop specific therapeutic agents for delivery directly to the relevant tissue, thus making therapeutic applications across many diseases. This holds safer and more efficacious treatments than injectable agents. The company has a strong research and development pipeline with stage candidate in Phase IIb, and an extensive portfolio of candidates ready for clinical development across a wide range of potential indications. ActoBio Therapeutics was founded on 2006 and is headquartered in Ghent. Belgium.

#SimilarOrganizations #People #Website #More

ACTOBIO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Wellness

Founded:
2006-01-01

Address:
Ghent, Oost-Vlaanderen, Belgium

Country:
Belgium

Website Url:
http://www.actobio.com

Total Employee:
11+

Status:
Closed

Contact:
+32 9 277 11 77

Email Addresses:
[email protected]

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator Barracuda Networks


Similar Organizations

exponential-biotherapies-logo

Exponential Biotherapies

Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.

monument-therapeutics-logo

Monument Therapeutics

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

not_available_image

Pan Therapeutics

Pan Therapeutics develops novel virus-based anti-cancer drugs for the treatment of cancer patients and domestic pets.

parvus-therapeutics-logo

Parvus Therapeutics

Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.

Current Employees Featured

luc-van-fraeyenhoven_image

Luc Van fraeyenhoven
Luc Van fraeyenhoven Chief Financial Officer @ ActoBio Therapeutics
Chief Financial Officer
2014-11-01

stefan-herdinius_image

Stefan Herdinius
Stefan Herdinius Vice President Strategic Drug Development @ ActoBio Therapeutics
Vice President Strategic Drug Development
2018-04-01

lothar-steidler_image

Lothar Steidler
Lothar Steidler Chief Technology Officer @ ActoBio Therapeutics
Chief Technology Officer
2018-01-01

pieter-rottiers_image

Pieter Rottiers
Pieter Rottiers Chief Executive Officer @ ActoBio Therapeutics
Chief Executive Officer
2018-01-01

Official Site Inspections

http://www.actobio.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ActoBio Therapeutics" on Search Engine